Dr. Ryan Sullivan is Assistant in Medicine and a member of the Center for Melanoma and Teermer Center for Targeted Therapy at Massachusetts General Hospital Cancer Center. He also serves as Assistant Professor at Harvard Medical School and is a member on the Dana-Farber/Harvard Cancer Center Institutional Review Board. Dr. Sullivan’s main areas of interest are the development of novel molecular therapeutic agents for malignant melanoma, the translation of promising preclinical findings into early stage clinical trials, and the development of predictive biomarkers for these investigational as well as standard treatment approaches.
Dr. Sullivan attended University of Connecticut School of Medicine followed by a residency at Mount Auburn Hospital and a fellowship at Beth Israel Deaconess Medical Center. He is board certified in Medical Oncology.